ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,000,000 | +22.2% | 43,723 | +34.1% | 0.02% | +40.0% |
Q2 2020 | $1,637,000 | +51.4% | 32,615 | +55.1% | 0.02% | +50.0% |
Q1 2020 | $1,081,000 | -83.1% | 21,029 | -79.7% | 0.01% | -73.7% |
Q4 2019 | $6,391,000 | +50.3% | 103,454 | +46.2% | 0.04% | +52.0% |
Q3 2019 | $4,251,000 | +1128.6% | 70,768 | +1628.2% | 0.02% | +1150.0% |
Q2 2019 | $346,000 | -94.5% | 4,095 | -94.4% | 0.00% | -93.3% |
Q3 2018 | $6,253,000 | -32.1% | 73,166 | -7.9% | 0.03% | -28.6% |
Q2 2018 | $9,208,000 | +12.0% | 79,447 | -21.8% | 0.04% | +10.5% |
Q1 2018 | $8,221,000 | +40.7% | 101,604 | +2.1% | 0.04% | +52.0% |
Q4 2017 | $5,841,000 | +288.1% | 99,548 | +209.5% | 0.02% | +257.1% |
Q3 2017 | $1,505,000 | -77.6% | 32,167 | -84.0% | 0.01% | -75.0% |
Q4 2016 | $6,714,000 | -37.9% | 200,422 | -50.7% | 0.03% | -39.1% |
Q3 2016 | $10,811,000 | +736.1% | 406,265 | +592.8% | 0.05% | +666.7% |
Q2 2016 | $1,293,000 | -49.8% | 58,643 | -33.1% | 0.01% | -45.5% |
Q1 2016 | $2,576,000 | +260.3% | 87,716 | +343.5% | 0.01% | +266.7% |
Q3 2015 | $715,000 | -81.5% | 19,778 | -77.0% | 0.00% | -82.4% |
Q2 2015 | $3,872,000 | – | 86,060 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |